KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Current Leases (2019 - 2025)

Historic Current Leases for Pacira BioSciences (PCRX) over the last 7 years, with Q3 2025 value amounting to $9.7 million.

  • Pacira BioSciences' Current Leases rose 606.03% to $9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.7 million, marking a year-over-year increase of 606.03%. This contributed to the annual value of $8.9 million for FY2024, which is 97.72% up from last year.
  • As of Q3 2025, Pacira BioSciences' Current Leases stood at $9.7 million, which was up 606.03% from $9.6 million recorded in Q2 2025.
  • Over the past 5 years, Pacira BioSciences' Current Leases peaked at $9.7 million during Q3 2025, and registered a low of $5.5 million during Q1 2021.
  • For the 5-year period, Pacira BioSciences' Current Leases averaged around $8.4 million, with its median value being $8.9 million (2024).
  • Per our database at Business Quant, Pacira BioSciences' Current Leases crashed by 2593.18% in 2021 and then skyrocketed by 4570.23% in 2022.
  • Pacira BioSciences' Current Leases (Quarter) stood at $7.9 million in 2021, then rose by 15.59% to $9.1 million in 2022, then fell by 3.51% to $8.8 million in 2023, then rose by 0.98% to $8.9 million in 2024, then grew by 9.69% to $9.7 million in 2025.
  • Its Current Leases was $9.7 million in Q3 2025, compared to $9.6 million in Q2 2025 and $9.4 million in Q1 2025.